Is a complete GMED research report available?

No complete published report is available for Globus Medical, Inc. (GMED) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

GMED Stock Analysis, Forecast & Valuation

Market cap	11.1B
Revenue (ttm)	3.1B
Net income (ttm)	586.7M
EPS (ttm)	$4.29
Shares out	135.7M
P/E (trailing)	19.0x
P/E (forward)	17.0x
Volume	1,336,575
Beta	0.95

Price target	$104	+27.6%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All GMED indicators

Market & fundamental data

Available fields

273

Groups with data

Currency

USD

Showing 273 of 273 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001237831
Company name	Globus Medical, Inc.
Country	United States
Country code	US
Cusip	379577208
Employees	6,000
Employees Change	700%
Employees Change Percent	13.21
Enterprise value	$10.4B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.96
Industry PE Fwd	19.8
IPO Date	2012-08-03
Isin	US3795772082
Last refreshed	2026-07-30
Market cap	$11.1B
Market cap category	Large-Cap
Price	$81.42
Price currency	USD
Rev Per Employee	516,777.33x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	3841
Symbol	GMED
Website	https://www.globusmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.31%
EV Earnings	17.67x
EV Sales Forward	3.19x
EV/EBIT	19.45x
EV/EBITDA	12.73x
EV/FCF	16.99x
EV/Sales	3.34x
FCF yield	5.52%
Forward P/E	16.95x
P/B ratio	2.33x
P/E ratio	18.98x
P/S ratio	3.56x
PE Ratio10 Y	46.3x
PE Ratio3 Y	68.42x
PE Ratio5 Y	57.44x
PEG ratio	1.48x
PS Forward	3.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.2%
EBITDA Margin	26.26%
FCF margin	19.68%
Gross margin	68.49%
Gross Profit	$2.1B
Gross Profit Growth	26.16%
Gross Profit Growth Q	30.54%
Gross Profit Growth3 Y	38.83%
Gross Profit Growth5 Y	28.67%
Net Income	$586.7M
Net Income Growth	216.18%
Net Income Growth Q	64.72%
Net Income Growth Quarters	7%
Net Income Growth Years	1%
Net Income Growth3 Y	42.86%
Net Income Growth5 Y	36.98%
Pretax Margin	21.24%
Profit Margin	18.92%
Profit Per Employee	$97,785
Profitable Quarters	$8
Profitable Years	17
ROA	8.18
Roa5y	6.25
ROCE	10.76
ROE	13.3
Roe5y	7.76
ROIC	14.16
Roic5y	11.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.74%
Cagr1y	49.99%
Cagr3y	10.14%
Cagr5y	-0.38%
EPS Growth	221.1
EPS Growth Q	66.67
EPS Growth Quarters	7
EPS Growth Years	1
EPS Growth3 Y	29.79
EPS Growth5 Y	28.96
FCF Growth	16.79%
FCF Growth Q	15.26%
FCF Growth3 Y	73.42%
FCF Growth5 Y	29.89%
OCF Growth	20.6%
OCF Growth Q	14.14%
OCF Growth10 Y	18.48%
OCF Growth3 Y	60.84%
OCF Growth5 Y	28.75%
Revenue Growth	23.49x
Revenue Growth Q	27.04x
Revenue Growth Quarters	4x
Revenue Growth Years	16x
Revenue Growth3 Y	42.61x
Revenue Growth5 Y	30.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.61
Assets	$5.4B
Cash	$629.9M
Current Assets	$2.2B
Current Liabilities	$482.5M
Debt	$115.9M
Debt EBITDA	$0.14
Debt Equity	$0.02
Debt FCF	$0.19
Equity	$4.7B
Liabilities	$707.2M
Long Term Assets	$3.2B
Long Term Liabilities	$224.8M
Net Cash	$683.3M
Net Cash By Market Cap	$6.18
Net Cash Growth	85.45%
Net Debt EBITDA	$-0.84
Net Debt Equity	$-0.14
Net Debt FCF	$-1.12
Tangible Book Value	$2.6B
Tangible Book Value Per Share	$18.96
WACC	9.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.56
Inventory Turnover	1.36
Net Working Capital	$1.1B
Quick ratio	2.83
Working Capital	$1.7B
Working Capital Turnover	$2.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.66%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	262.19%
1Y total return	49.95%
200-day SMA	83.72
3Y total return	33.61%
50-day SMA	79.71
50-day SMA vs 200-day SMA	50under200
5Y total return	-1.89%
All Time High	101.4
All Time High Change	-19.7%
All Time High Date	2026-01-08
All Time Low	10.26
All Time Low Change	693.57%
All Time Low Date	2012-12-31
ATR	2.87
Beta	0.95
Beta1y	0.33
Beta2y	0.65
Ch YTD	-6.75
High	81.62
High52	101.4
High52 Date	2026-01-08
High52ch	-19.7%
Low	79.58
Low52	51.79
Low52 Date	2025-08-01
Low52ch	57.21%
Ma50ch	2.14%
Premarket Change Percent	-0.11
Premarket Price	$80.49
Premarket Volume	12,357
Price vs 200-day SMA	-2.75%
RSI	56.08
RSI Monthly	53.85
RSI Weekly	48.96
Sharpe ratio	0.96x
Sortino ratio	2.25
Total Return	1.66%
Tr YTD	-6.75
Tr1m	-5.6%
Tr1w	7.84%
Tr3m	-10.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	3
Analyst Price Target Top	$110
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$1.1
Earnings EPS Estimate Growth	27.91
Earnings Revenue Estimate	783,779,192x
Earnings Revenue Estimate Growth	5.16x
Operating Income	$664M
Operating Income Growth	47.15
Operating Income Growth Q	64.84
Operating Income Growth3 Y	39.36
Operating Income Growth5 Y	36.29
Operating margin	21.41
Price target	$104
Price Target Change	$27.63
Price Target Change Top	$35.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	111,700,045%
Float Percent	82.29%
Shares Insiders	17.52%
Shares Institutions	83.51%
Shares Out	135,744,626
Shares Qo Q	1.18%
Shares Yo Y	-1.66%
Short Float	6.33%
Short Ratio	3.48
Short Shares	5.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$561.1M
Adjusted OCF	729,321,000
Average Volume	1,730,923.25x
Bv Per Share	34.88
CAPEX	$-168.2M
Ch10y	262.2
Ch1m	-5.6
Ch1w	7.84
Ch1y	49.95
Ch3m	-10.27
Ch3y	33.61
Ch5y	-1.89
Ch6m	-11.34
Change	1.04%
Change From Open	1.83
Close	80.58
Days Gap	-0.77
Depreciation Amortization	281,074,000
Dollar Volume	108,823,936.5
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$533.2M
EBITDA	$814.2M
EPS	$4.29
F Score	7
FCF	$610.3M
FCF EV Yield	5.89x
FCF Per Share	$4.5
Financing CF	-25,567,000
Fiscal Year End	December
Founded	2,003
Goodwill	1,438,733,000
Graham Number	58.01986
Graham Upside	-28.74
Income Tax	$71.8M
Investing CF	-669,073,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Lynch Fair Value	$107
Lynch Upside	31.7
Ma150	86.14
Ma150ch	-5.48%
Ma20	77.91
Ma20ch	4.51%
Net CF	99,684,000
Next Earnings Date	2026-08-06
Open	79.96
Optionable	Yes
P FCF Ratio	18.11
P FCF Ratio SBC	19.7
P OCF Ratio	14.2
P OCF Ratio SBC	15.15
Position In Range	90.2
Post Close	81.42
Postmarket Change Percent	-0.82
Postmarket Price	$80.75
Ppne	619,343,000
Pre Close	80.58
Price Date	2026-07-29
Price EBITDA	$13.57
Ptbv Ratio	4.3
Relative Volume	0.77x
Revenue	3,100,664,000x
SBC By Revenue	1.59x
Share Based Comp	49,190,000
Tax By Revenue	2.31x
Tax Rate	10.9%
Tr6m	-11.34%
Us State	Pennsylvania
Volume	1,336,575
Z Score	9.96

Globus Medical, Inc. (GMED)

Coverage state: Market snapshot only — no published research

Generate the first GMED analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · GMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on GMED

Frequently asked questions